
Stereotaxis Inc (STXS) Stock Forecast & Price Target
Stereotaxis Inc (STXS) Analyst Ratings
Bulls say
Stereotaxis is expected to see significant growth and leverage in their business as regulatory and commercial milestones are achieved, with the potential for cash flow positivity in the next few years. The company has a strong focus on expanding its presence in robotics and automation with recurring revenue, and their recent collaboration with CardioFocus on a robotic Pulsed Field Ablation system adds to their innovative portfolio. Additionally, the company has a solid financial standing, with increasing revenue growth and a healthy cash position.
Bears say
Stereotaxis is focusing on expanding its product portfolio while waiting for key products to receive FDA clearance, which poses significant delays and risks. The company faces competitive and reimbursement risks, as well as potential challenges with regulatory approvals and supply chain management. Furthermore, the company's recent collaboration with CardioFocus may not bring immediate revenue growth and success, and may face challenges in clinical trials and regulatory reviews.
This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.
Stereotaxis Inc (STXS) Analyst Forecast & Price Prediction
Start investing in Stereotaxis Inc (STXS)
Order type
Buy in
Order amount
Est. shares
0 shares